Search - tctmd.com

Displaying 241 - 260 of 390

Sort: Relevancy | Date

Presentation TCT 2014

Special Lecture: Predicting the EXCEL Results from the SYNTAX Score II

Presenter: Davide Capodanno, Evald H. Christiansen, R. Stefan Kiesz, Patrick W. Serruys

September 16, 2014

Presentation TCT 2014

Left Main Stent Thrombosis: New Insights Into the Scope of the Problem

Presenter: Davide Capodanno, Evald H. Christiansen, R. Stefan Kiesz, Patrick W. Serruys

September 16, 2014

Presentation TCT 2014

Featured Lecture: ABSORB II: What Has the Randomized Trial Taught us Beyond the Registries?

Presenter: Mitchell W. Krucoff, John A. Ormiston, Robert-Jan van Geuns, Patrick W. Serruys

September 16, 2014

Presentation TCT 2014

Case Study: Recurrent Stent Thrombosis

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Tullio Palmerini

September 14, 2014

Presentation TCT 2014

Hematologic Etiologies of Stent Thrombosis and How to Evaluate

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Giulio G. Stefanini

September 14, 2014

Presentation TCT 2014

Evaluation and Treatment of Stent Thrombosis: From Acute Patency to Long-term Vascular Stability

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Ron Waksman

September 14, 2014

Presentation TCT 2014

Are Current DES Really Safer Than BMS?

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Tullio Palmerini

September 14, 2014

Presentation TCT 2014

Beyond the Guidelines: What Is the Optimal Duration of DAPT After Metallic DES Implantation, and Is It Device Specific?

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Marco Valgimigli

September 14, 2014

Presentation TCT 2014

Prevention of Stent Thrombosis: Devices, Pharmacology, Technique, Patients, and More

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Lorenz Raber

September 14, 2014

Presentation TCT 2014

Focal Treatment of Vulnerable Plaque: Stents, Scaffolds, and Prospect ABSORB

Presenter: Valentin Fuster, Patrick W. Serruys, Gregg W. Stone

September 14, 2014

Presentation TCT 2014

Systemic Therapies for the At-Risk Patient: From Darapladib to Anti-inflammatories and PCSK9 Inhibitors

Presenter: Valentin Fuster, Patrick W. Serruys, Harvey D. White

September 14, 2014

Presentation TCT 2014

Invasive Imaging for Vulnerable Plaque: Comparing and Contrasting VH-IVUS, OCT, and NIRS

Presenter: Valentin Fuster, Patrick W. Serruys, Akiko Maehara

September 14, 2014

Presentation TCT 2014

Advances in Molecular Imaging of High-Risk Plaque: PET and Beyond

Presenter: Valentin Fuster, Patrick W. Serruys, Farouc Jaffer

September 14, 2014

Presentation TCT 2014

Noninvasive Imaging Modalities for Coronary VP Detection: CT, MR, and CIMT

Presenter: Valentin Fuster, Patrick W. Serruys, Jagat Narula

September 14, 2014

Presentation TCT 2014

Natural History of Vulnerable Plaque: Targets for Risk Stratification

Presenter: Valentin Fuster, Patrick W. Serruys, Peter H. Stone

September 14, 2014

Presentation TCT 2014

ABSORB II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus an Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease

Presenter: Gregg W. Stone, Pieter C. Smits, Patrick W. Serruys

September 14, 2014

News Conference News TCT 2014

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

Yael L. Maxwell

September 14, 2014

News Industry News

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

September 14, 2014

Presentation TCT 2014

Lessons from the Global Valve-in-Valve Registry

Presenter: Patrick W. Serruys, E. Murat Tuzcu, Ian T. Meredith, Danny Dvir

September 13, 2014

Presentation TCT 2014

TCT 689: Three- and Five-Year Outcomes after Transcatheter Aortic Valve Implantation in High-Risk Patients with Severe Aortic Stenosis: The U.K. TAVI (United Kingdom Aortic Valve Implantation) Registry

Presenter: Patrick W. Serruys, E. Murat Tuzcu, Ian T. Meredith, Alison Duncan

September 13, 2014

Advertisement

Special Lecture: Predicting the EXCEL Results from the SYNTAX Score II

Left Main Stent Thrombosis: New Insights Into the Scope of the Problem

Featured Lecture: ABSORB II: What Has the Randomized Trial Taught us Beyond the Registries?

Case Study: Recurrent Stent Thrombosis

Hematologic Etiologies of Stent Thrombosis and How to Evaluate

Evaluation and Treatment of Stent Thrombosis: From Acute Patency to Long-term Vascular Stability

Are Current DES Really Safer Than BMS?

Beyond the Guidelines: What Is the Optimal Duration of DAPT After Metallic DES Implantation, and Is It Device Specific?

Prevention of Stent Thrombosis: Devices, Pharmacology, Technique, Patients, and More

Focal Treatment of Vulnerable Plaque: Stents, Scaffolds, and Prospect ABSORB

Systemic Therapies for the At-Risk Patient: From Darapladib to Anti-inflammatories and PCSK9 Inhibitors

Invasive Imaging for Vulnerable Plaque: Comparing and Contrasting VH-IVUS, OCT, and NIRS

Advances in Molecular Imaging of High-Risk Plaque: PET and Beyond

Noninvasive Imaging Modalities for Coronary VP Detection: CT, MR, and CIMT

Natural History of Vulnerable Plaque: Targets for Risk Stratification

ABSORB II: A Prospective, Randomized Trial of an Everolimus-Eluting Bioresorbable Scaffold Versus an Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

Lessons from the Global Valve-in-Valve Registry

TCT 689: Three- and Five-Year Outcomes after Transcatheter Aortic Valve Implantation in High-Risk Patients with Severe Aortic Stenosis: The U.K. TAVI (United Kingdom Aortic Valve Implantation) Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content